Proscia Accelerates AI-Driven Pathology, Surges to 32,000 Daily Diagnoses on Concentriq Platform

Proscia

PHILADELPHIA, PAProscia® is poised to diagnose 32,000 patients daily on its Concentriq® software platform by year-end, marking a remarkable 400% year-over-year growth and reinforcing the company’s role as a leader in AI-powered pathology solutions.

The surge in adoption highlights Proscia’s success in helping major laboratories unlock the operational, clinical, and financial potential of digital pathology at scale. Backed by global software investor Insight Partners, Proscia has rapidly expanded its reach, fueling millions in new high-margin revenue opportunities for participating diagnostic networks.

Central to this growth are Proscia’s newly launched AI application suites. These pre-configured offerings consolidate cancer detection, scoring, and quality control tools into streamlined packages for critical use cases in breast, prostate, gastric, and colon cancers. By simplifying adoption and providing a unified user experience, the suites help laboratories standardize interpretation, enhance operational efficiency, and generate actionable insights at scale.

READ:  Nuvem Expands Leadership Team With Four Executive Hires to Strengthen Pharmacy Support for Community Health Providers

“Through our diagnostic network, laboratories are not only recouping the cost of going digital but also unlocking high-margin revenue opportunities reshaping their economics,” said Tom Gallo, Chief Financial Officer at Proscia.

Complementing these technology advancements is Proscia’s launch of 24/7 customer support, designed to meet the demands of global, high-throughput laboratory operations. The expanded support offering reflects the company’s proactive, partnership-driven approach. According to a KLAS Research report, Proscia received an ‘A+’ for support quality, with 100% of surveyed customers saying they would purchase again and view Proscia as a long-term partner.

Additionally, Proscia has now integrated Concentriq with over 100 laboratory information system (LIS) instances—including Epic Beaker and CoPath—demonstrating its commitment to seamless digital workflows. These integrations enable robust bidirectional data exchange, enhancing accuracy and speed in high-volume laboratory environments.

READ:  Over 75% of Americans Underestimate the Savings - $1,000 or More - By Switching to Xfinity Mobile New Survey Shows

Proscia’s diagnostic network, launched in 2024, has opened new revenue channels for laboratories through real-world data monetization, pharmaceutical services, and acting as AI validation testbeds. With more than 12 million whole slide images linked to molecular and genomic data, participating labs offer a rich dataset for biopharma partners seeking to advance precision medicine.

As Proscia scales its platform and expands its AI portfolio, it remains at the forefront of transforming pathology into a data-rich, digitally driven discipline—reshaping laboratory economics and ultimately improving patient outcomes worldwide.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.